Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Liquid Biopsy Test Identifies Over 1,000 Pathogens from Single Blood Draw within 24 Hours

By LabMedica International staff writers
Posted on 11 Oct 2023

Pneumonia poses a serious health risk, especially for those currently being treated for blood cancer, who are generally more susceptible to infections. More...

Identifying the exact cause of pneumonia in such patients is both challenging and vital for effective treatment. Now, a blood test based on metagenomics next-generation sequencing (NGS) of microbial cell-free DNA has been shown to increase the identification of pathogens causing pneumonia in immunocompromised patients when combined with routine care diagnostic testing.

The Karius Test from Karius Inc. (Redwood City, CA, USA) is a liquid biopsy that can rapidly and non-invasively identify over 1,000 types of pathogens from just one blood sample. Its primary function is to assist doctors in diagnosing infections in immunocompromised patients. The test can identify a range of conditions, including pneumonia, invasive fungal infections, and others that could lead to fever in neutropenic patients. This innovative test could eliminate the need for multiple, invasive, and often inefficient diagnostic procedures, speeding up treatment for those who are critically ill. Results from the Karius Test are usually available the day after the sample is received, which is much faster than standard testing procedures that can take several days or even weeks.

The PICKUP Study, a pioneering collaborative research effort by ten top medical institutions, explored the additional diagnostic value that the Karius Test could provide in treating pneumonia in blood cancer patients. This study specifically looked at the percentage of patients for whom the Karius Test could identify the pneumonia-causing pathogen when standard diagnostic tests had failed to do so within seven days of admission. The study found that the test accurately identified the likely cause of pneumonia in 12% (21 out of 173) of patients when all other tests, including bronchoscopy, had failed. The research also highlighted that for 81% (17 out of 21) of these patients, the treatment could have been more effectively tailored if the Karius Test had been used. Moreover, the test was successful in detecting hard-to-identify pathogens such as Rhizomucor pusillus, Nocardia cyriacigeorgica, Legionella species, and Aspergillus fumigatus, among others, where traditional tests had come up short.

“These patients have much to gain through an improved etiologic diagnosis, and the better and more directed treatment of these infections that make this possible,” said Brad Perkins, Chief Medical Officer at Karius. “This is not only beneficial in the avoidance of the direct morbidity and mortality associated with these infections (26.6% of our enrolled patients died during this study) but in also gaining earlier and uninterrupted access to in-many-cases increasingly life-saving treatments for their underlying disease, in this case hematologic malignancies.”

Related Links:
Karius Inc. 


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Capillary Blood Collection Tube
IMPROMINI M3
New
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.